Prophylactic antibiotics in intra-oral bone grafting procedures: a prospective, randomized, double-blind clinical trial.
10.5125/jkaoms.2012.38.2.90
- Author:
Jung Woo LEE
1
;
Jin Yong LEE
;
Soung Min KIM
;
Myung Jin KIM
;
Jong Ho LEE
Author Information
1. Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University, Seoul, Korea. leejongh@snu.ac.kr
- Publication Type:Clinical Trial ; Randomized Controlled Trial ; Original Article
- Keywords:
Intra-oral bone graft;
Prophylactic antibiotics;
Surgical site infection
- MeSH:
Anti-Bacterial Agents;
Bone Transplantation;
Humans;
Incidence;
Prospective Studies;
Random Allocation;
Surgical Wound Infection;
Transplants
- From:Journal of the Korean Association of Oral and Maxillofacial Surgeons
2012;38(2):90-95
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: This study was conducted in order to assess the efficacy of 1st generation cephalosporin as use as a single-dose preoperative prophylactic antibiotic for surgical wound infections resulting from intra-oral bone grafting procedures. MATERIALS AND METHODS: A total of 23 patients who were to undergo intra-oral bone graft procedures participated in this study. After randomization, 2 grams of 1st generation cephalosporin was orally administered to both the experimental and placebo groups one hour prior to surgery in a double-blind fashion. Post-operatively, the experimental group (12 patients) was orally administered placebo three times a day for three days. The control group (11 patients) was orally administered 1st generation cephalosporin three times a day for three days. The postoperative course was observed for one month including the clinical parameters associated with infection. RESULTS: Postoperative infections were noted in 1 out of 11 patients in the experimental group. No infections occurred in the control group. CONCLUSION: There was no significant difference in the incidence of postoperative infections between the two groups. Two grams of 1st generation cephalosporin administered orally one hour before surgery served as an effective prophylactic antibiotics therapy for intra-oral bone graft surgery
